Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Impact of coxsackievirus-B4E2 combined with a single low dose of streptozotocin on pancreas of outbred mice: investigation of viral load, pathology and inflammation.

Benkahla MA, Sane F, Bertin A, Vreulx AC, Elmastour F, Jaidane H, Desailloud R, Hober D.

Sci Rep. 2019 Jul 12;9(1):10080. doi: 10.1038/s41598-019-46227-3.

2.

Coxsackievirus-B4 Infection of Human Primary Pancreatic Ductal Cell Cultures Results in Impairment of Differentiation into Insulin-Producing Cells.

Bertin A, Sane F, Gmyr V, Lobert D, Dechaumes A, Kerr-Conte J, Pattou F, Hober D.

Viruses. 2019 Jul 2;11(7). pii: E597. doi: 10.3390/v11070597.

3.

Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.

Nekoua MP, Bertin A, Sane F, Alidjinou EK, Lobert D, Trauet J, Hober C, Engelmann I, Moutairou K, Yessoufou A, Hober D.

Cell Mol Life Sci. 2019 Jun 6. doi: 10.1007/s00018-019-03168-4. [Epub ahead of print]

PMID:
31172216
4.

Emergence of Fluoxetine-Resistant Variants during Treatment of Human Pancreatic Cell Cultures Persistently Infected with Coxsackievirus B4.

Alidjinou EK, Bertin A, Sane F, Caloone D, Engelmann I, Hober D.

Viruses. 2019 May 28;11(6). pii: E486. doi: 10.3390/v11060486.

5.

Aqueous extracts of Syzygium brazzavillense can inhibit the infection with coxsackievirus B4 in vitro.

Badia-Boungou F, Sane F, Alidjinou EK, Hennebelle T, Roumy V, Ngakegni-Limbili AC, Nguimbi E, Moukassa D, Abena AA, Hober D.

J Med Virol. 2019 Jul;91(7):1210-1216. doi: 10.1002/jmv.25436. Epub 2019 Mar 3.

PMID:
30788849
6.

Diabetes progression and alterations in gut bacterial translocation: prevention by diet supplementation with human milk in NOD mice.

Sane F, Scuotto A, Pierrat V, Kacet N, Hober D, Romond MB.

J Nutr Biochem. 2018 Dec;62:108-122. doi: 10.1016/j.jnutbio.2018.08.017. Epub 2018 Oct 4.

PMID:
30292969
7.

Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo.

Benkahla MA, Alidjinou EK, Sane F, Desailloud R, Hober D.

Antiviral Res. 2018 Nov;159:130-133. doi: 10.1016/j.antiviral.2018.10.002. Epub 2018 Oct 2.

PMID:
30290197
8.

Serum-derived IgG from coxsackievirus A6-infected patients can enhance the infection of peripheral blood mononuclear cells with coxsackievirus A6.

Aswathyraj S, Sane F, Raghu C, Sabeena S, Alidjinou EK, Arunkumar G, Hober D.

Microb Pathog. 2018 Dec;125:7-11. doi: 10.1016/j.micpath.2018.08.064. Epub 2018 Sep 4.

PMID:
30193952
9.

miRNAs in enterovirus infection.

Engelmann I, Alidjinou EK, Bertin A, Sane F, Hober D.

Crit Rev Microbiol. 2018 Nov;44(6):701-714. doi: 10.1080/1040841X.2018.1499608. Epub 2018 Aug 14. Review.

PMID:
30106324
10.

Salivary anti-coxsackievirus-B4 neutralizing activity and pattern of immune parameters in patients with type 1 diabetes: a pilot study.

Nekoua MP, Yessoufou A, Alidjinou EK, Badia-Boungou F, Moutairou K, Sane F, Hober D.

Acta Diabetol. 2018 Aug;55(8):827-834. doi: 10.1007/s00592-018-1158-3. Epub 2018 May 17.

PMID:
29774468
11.

Inhibition of coxsackievirus B4 by Lactobacillus plantarum.

Arena MP, Elmastour F, Sane F, Drider D, Fiocco D, Spano G, Hober D.

Microbiol Res. 2018 May;210:59-64. doi: 10.1016/j.micres.2018.03.008. Epub 2018 Mar 19.

12.

Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins.

Bulanova D, Ianevski A, Bugai A, Akimov Y, Kuivanen S, Paavilainen H, Kakkola L, Nandania J, Turunen L, Ohman T, Ala-Hongisto H, Pesonen HM, Kuisma MS, Honkimaa A, Walton EL, Oksenych V, Lorey MB, Guschin D, Shim J, Kim J, Than TT, Chang SY, Hukkanen V, Kulesskiy E, Marjomaki VS, Julkunen I, Nyman TA, Matikainen S, Saarela JS, Sane F, Hober D, Gabriel G, De Brabander JK, Martikainen M, Windisch MP, Min JY, Bruzzone R, Aittokallio T, Vähä-Koskela M, Vapalahti O, Pulk A, Velagapudi V, Kainov DE.

Viruses. 2017 Sep 25;9(10). pii: E271. doi: 10.3390/v9100271.

13.

Enteroviruses in blood of patients with type 1 diabetes detected by integrated cell culture and reverse transcription quantitative real-time PCR.

Alidjinou EK, Sane F, Lefevre C, Baras A, Moumna I, Engelmann I, Vantyghem MC, Hober D.

Acta Diabetol. 2017 Nov;54(11):1025-1029. doi: 10.1007/s00592-017-1041-7. Epub 2017 Aug 31.

PMID:
28861621
14.

Evaluation of Contamination Risks with Coxsackievirus B4 E2 in Swiss Albino Mice Stools.

Aguech-Oueslati L, Jaidane H, Sane F, Jrad-Battikh N, Hamed SB, Hober D, Gharbi J.

Curr Microbiol. 2018 Jan;75(1):32-39. doi: 10.1007/s00284-017-1347-2. Epub 2017 Aug 30.

PMID:
28856411
15.

Resistance of Enteric Viruses on Fomites.

Alidjinou EK, Sane F, Firquet S, Lobert PE, Hober D.

Intervirology. 2018;61(5):205-213. doi: 10.1159/000448807. Epub 2017 Jun 15. Review.

16.

Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells.

Engelmann I, Alidjinou EK, Bertin A, Bossu J, Villenet C, Figeac M, Sane F, Hober D.

Cell Mol Life Sci. 2017 Oct;74(20):3851-3861. doi: 10.1007/s00018-017-2567-0. Epub 2017 Jun 10.

PMID:
28601984
17.

Bifidobacteria-derived lipoproteins inhibit infection with coxsackievirus B4 in vitro.

El Kfoury KA, Romond MB, Scuotto A, Alidjinou EK, Dabboussi F, Hamze M, Engelmann I, Sane F, Hober D.

Int J Antimicrob Agents. 2017 Aug;50(2):177-185. doi: 10.1016/j.ijantimicag.2017.03.010. Epub 2017 Jun 17.

PMID:
28595938
18.

Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4.

Elmastour F, Jaïdane H, Benkahla M, Aguech-Oueslati L, Sane F, Halouani A, Engelmann I, Bertin A, Mokni M, Gharbi J, Aouni M, Alidjinou EK, Hober D.

Virulence. 2017 Aug 18;8(6):908-923. doi: 10.1080/21505594.2016.1252018. Epub 2016 Oct 28.

19.

Exposure of Piglets to Enteroviruses Investigated by an Immunoassay Based on the EV-G1 VP4 Peptide.

Benkahla MA, Sane F, Desailloud R, Hober D.

Intervirology. 2016;59(2):69-73. doi: 10.1159/000449058. Epub 2016 Oct 1.

20.

Central nervous system infection following vertical transmission of Coxsackievirus B4 in mice.

Jmii H, Halouani A, Elmastour F, Ifie E, Richardson SJ, Sane F, Mokni M, Aouni M, Hober D, Jaïdane H.

Pathog Dis. 2016 Sep 20. pii: ftw096. [Epub ahead of print]

PMID:
27655912

Supplemental Content

Loading ...
Support Center